成交金额(万元) 康龙化成12月18日大宗交易平台出现一笔成交，成交量100.00万股，成交金额2874.00万元，大宗交易成 交价为28.74元，相对今日收盘价折价0.90%。该笔交易的买方营业部为机构专用，卖方营业部为中信证 券华南股份有限公司广州万博证券营业部。 进一步统计，近3个月内该股累计发生5笔大宗交易，合计成交金额为9643.49万元。 证券时报·数据宝统计显示，康龙化成今日收盘价为29.00元，下跌0.65%，日换手率为0.91%，成交额为 3.79亿元，全天主力资金净流出1319.15万元，近5日该股累计下跌0.17%，近5日资金合计净流出5191.63 万元。 两融数据显示，该股最新融资余额为10.83亿元，近5日减少1504.03万元，降幅为1.37%。 据天眼查APP显示，康龙化成(北京)新药技术股份有限公司成立于2004年07月01日，注册资本 177819.5525万人民币。 12月18日康龙化成大宗交易一览 成交量(万股) 成交价格(元) 相对当日收盘折溢价 (%) 买方营业部卖方营业部 100.00 2874.00 28.74 -0.90 机构专用 中信证券华南股份有限公司广州 ...

Core Insights - The Shanghai Children's Medical Center in Linyi is set to officially operate in June 2024, establishing six major treatment centers for pediatric cardiovascular, hematology-oncology, rare diseases, surgery, neurological disorders, and critical care, aiming to provide high-quality medical services for children aged 0-18 [1][2] - The establishment of national regional medical centers is a significant decision by the government, aimed at expanding high-quality medical resources and enabling local access to top-tier medical services without the need to travel to major cities like Beijing and Shanghai [1] - The Linyi hospital is the only pediatric project among the nine national regional medical centers in the province, with a total investment of 1.885 billion yuan and a planned capacity of 1,000 beds [1] Government Support and Implementation - The Linyi municipal government has prioritized the project, implementing 22 supportive policies across various sectors including staffing, insurance, talent, and finance to facilitate the integration of Shanghai Children's Medical Center's expertise into the region [2] - The center has dispatched 21 resident experts and over 600 visiting experts to Linyi, introducing more than 70 new technologies and projects, significantly enhancing the local capacity for treating complex pediatric cases [2] - Notable advancements have been made in pediatric cardiovascular, neurosurgery, and oncology, with a reported 19% decrease in the transfer rate of critical cases to other provinces, indicating improved local treatment capabilities [2]

近日，第三届常委会第六次会议暨博鳌新技术临床应用交流会在海南博鳌医疗旅游先行区管理局召 开，会议聚焦新技术转化与临床应用展开专题探讨。琼海市委书记、乐城先行区管理局党委书记周长强 主持会议并锚定"健康中国"战略目标。博鳌地区可从政策机制、产业生态、临床落地三大核心维度，推 进"新技术转化及应用"的优化升级：政策机制侧重制度突破与流程提速，打通技术落地堵点；产业生态 侧强化产学研用协同，构建全链条创新网络；临床落地侧聚焦民生可及，推动技术从"能用"向"普惠能 用"转型，为医疗高质量发展注入新动能。 中国医院协会临床新技术应用委员会主委顾晓松院士明确2026年三大工作方向：一是扎根规范，保 障临床新技术安全可控，严格遵循行业监管要求；二是开创融合，推动新技术与临床，产业，地方，医 保及国际化融合，联动医院，医生与企业；三是走向开放，提升国内诊疗水平，参与国际标准制定，打 造硬核科技成果。 中国医院协会常务会长毛群安进一步指出，聚焦新技术应用规范，医保准入等核心诉求，发挥桥梁 作用，加强与医保局，药监局等部门沟通。强调818条例落地需细化配套措施，要求专委会梳理重点问 题，协同推进新技术临床应用与转化。提出未来五年 ...

Core Viewpoint - China Resources Medical (01515) has seen a slight increase in stock price, closing at 3.24 RMB, reflecting a 0.31% rise from the previous trading day. The company has disclosed further details regarding its health management service framework agreement, which involves significant projected coverage of employees and pricing structures for health check services [1]. Group 1: Stock Performance - As of December 18, 2025, the stock closed at 3.24 RMB, up 0.31% from the previous day [1] - The stock opened at 3.23 RMB, with a daily high of 3.25 RMB and a low of 3.21 RMB, achieving a transaction volume of 5.7015 million RMB [1] - The stock's 52-week high and low are 4.63 RMB and 3.18 RMB, respectively [1] Group 2: Health Management Service Framework Agreement - The company has released a supplementary announcement regarding the health management service framework agreement, detailing the annual transaction limits for the years 2025 to 2027, which are projected to cover approximately 20,000, 80,000, and 130,000 employees respectively [1] - The price per health check is estimated to range from 500 to 3,000 RMB, with buffer percentages of 34%, 13%, and 16% reserved for each year to accommodate business fluctuations [1] - Historical transaction amounts up to October 31, 2025, totaled approximately 2.28 million RMB, which does not fully reflect the seasonal demand for health checks at year-end [1] - The agreement was officially signed on December 4, 2025, with a retroactive service period starting from December 1, 2025, to enhance accounting and operational efficiency [1] - The applicable percentage rates for the related transactions are confirmed to be below 0.1%, and the annual limits are reiterated as fair and reasonable [1]

希玛医疗(03309)发布公告，于2025年12月18日，该公司斥资51.78万港元回购32万股股份，每股回购价 格为1.58-1.63港元。 ...

美年健康今日涨停，全天换手率14.08%，成交额31.81亿元，振幅9.45%。龙虎榜数据显示，机构净买入 6866.37万元，深股通净买入8311.12万元，营业部席位合计净买入1873.61万元。 深交所公开信息显示，当日该股因日涨幅偏离值达10.70%上榜，机构专用席位净买入6866.37万元，深 股通净买入8311.12万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交9.97亿元，其中，买入成交额为5.84亿 元，卖出成交额为4.13亿元，合计净买入1.71亿元。 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 国泰海通证券股份有限公司成都北一环路证券营业部 | 15074.29 | 16.91 | | 买二 | 深股通专用 | 11040.30 | 2729.19 | | 买三 | 国泰海通证券股份有限公司上海松江区中山东路证券营 业部 | 9723.21 | 52.15 | | 买四 | 机构专用 | 7685.31 | 818.94 | | 买五 | 国泰海 ...

美年健康公告称，公司股票（证券代码：002044）在2025年12月17日、18日连续两个交易日内收盘价格 涨幅偏离值累计超过20%，属股票交易异常波动情形。经自查，公司前期披露信息无需更正、补充，未 发现公共传媒报道可能影响股价的未公开重大信息，近期经营正常，内外部环境无重大变化，公司及实 控人无应披露未披露重大事项，实控人在此期间无买卖公司股票情形。公司提醒投资者注意风险。 ...

Core Viewpoint - The company is poised to leverage government policies supporting the development of social healthcare services, aiming to enhance medical service supply and optimize resource allocation in the healthcare sector [1] Group 1: Government Policies and Industry Context - The ongoing deepening of China's healthcare reform has led to a series of policy recommendations from central and local governments that encourage the development of social healthcare [1] - These policies are designed to increase the supply of medical services and ensure a rational allocation of healthcare resources [1] Group 2: Company Strategy and Operations - The company has over 20 years of experience in the healthcare industry, focusing on hospital construction, operation, and management [1] - It has developed a comprehensive lifecycle healthcare service platform, which is expected to enhance the utilization rate of hospital beds as the overall strength of hospitals improves and surrounding areas mature [1] - The company operates the Xi'an International Center Hospital, which has significant investment and currently has some vacant beds [1] Group 3: Future Growth Opportunities - The company plans to respond actively to national policies by seizing opportunities in the "silver economy," converting vacant beds into wellness beds to revitalize these assets [1] - This transformation of existing assets into high-value-added wellness services is expected to lay a solid foundation for future performance growth [1]

证券之星消息，12月18日医疗服务板块较上一交易日上涨0.47%，美年健康领涨。当日上证指数报收于 3876.37，上涨0.16%。深证成指报收于13053.98，下跌1.29%。医疗服务板块个股涨跌见下表： 从资金流向上来看，当日医疗服务板块主力资金净流入1.72亿元，游资资金净流出4.27亿元，散户资金 净流入2.54亿元。医疗服务板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 ...

（原标题：亚太股市普跌！AI医疗概念股集体走强 商业航天全线爆发） 【导读】又来找原因啦 大家好，不好意思，又来找下跌原因了。 隔夜美股科技板块大跌，泰勒以为这次我们会走出独立行情，没想到还是想多了！ A股下跌 12月18日，A股指数普遍下跌，仅沪指一枝独秀。截至收盘，沪指涨0.16%，深成指跌1.29%，创业板指 跌2.17%。 两市共2845只个股上涨，73只个股涨停，2416只个股下跌。 AI医疗概念股集体走强，华人健康、塞力医疗等涨停。消息面上，近日蚂蚁集团正式推出AI健康应 用"蚂蚁阿福"，月活跃用户规模超1500万，并登上苹果应用商店下载榜第二位。市场解读为AI技术与健 康管理场景的深度融合有望开启新增长空间，从而提振了板块整体情绪。 商业航天全线爆发，盛洋科技、天箭科技等涨停。有股民调侃称，"犒赏经济"重磅提出，商业航天迎来 重大利好。 零售、IP经济等消费股拉升，百大集团6连板，上海九百等涨停。 下跌方面，算力硬件股下挫，生益科技、景旺电子等跌超5%。 有分析师指出，近几周一个更清晰的叙事正在形成：推动本轮牛市的超大市值科技股，可能正在失去单 独"扛起市场"的能力。"市场对该板块的信心正面临挑 ...